Unknown

Dataset Information

0

Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2.

ABSTRACT: Inhibitors of viral cell entry based on poly(styrene sulfonate) and its core-shell nanoformulations based on gold nanoparticles are investigated against a panel of viruses, including clinical isolates of SARS-CoV-2. Macromolecular inhibitors are shown to exhibit the highly sought-after broad-spectrum antiviral activity, which covers most analyzed enveloped viruses and all of the variants of concern for SARS-CoV-2 tested. The inhibitory activity is quantified in vitro in appropriate cell culture models and for respiratory viral pathogens (respiratory syncytial virus and SARS-CoV-2) in mice. Results of this study comprise a significant step along the translational path of macromolecular inhibitors of virus cell entry, specifically against enveloped respiratory viruses.

SUBMITTER: Groß R 

PROVIDER: S-EPMC9284172 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Inhibitors of viral cell entry based on poly(styrene sulfonate) and its core-shell nanoformulations based on gold nanoparticles are investigated against a panel of viruses, including clinical isolates of SARS-CoV-2. Macromolecular inhibitors are shown to exhibit the highly sought-after broad-spectrum antiviral activity, which covers most analyzed enveloped viruses and all of the variants of concern for SARS-CoV-2 tested. The inhibitory activity is quantified in vitro in appropriate cell culture  ...[more]

Similar Datasets

Unknown Targeting viral entry as a strategy for broad-spectrum antivirals.
| S-EPMC6743247 | biostudies-literature
Unknown Preparing for the next viral threat with broad-spectrum antivirals.
| S-EPMC10232003 | biostudies-literature
Unknown Broad-spectrum antivirals of protoporphyrins inhibit the entry of highly pathogenic emerging viruses.
| S-EPMC7784547 | biostudies-literature
Unknown Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.
| S-EPMC6410080 | biostudies-literature
Unknown Modified cyclodextrins as broad-spectrum antivirals.
| S-EPMC6989148 | biostudies-literature
Unknown Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
| S-EPMC7402641 | biostudies-literature
Unknown Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants.
| S-EPMC10990083 | biostudies-literature
Unknown Drug repurposing for new, efficient, broad spectrum antivirals.
| S-EPMC7114681 | biostudies-literature
Unknown Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.
| S-EPMC7870000 | biostudies-literature
Unknown In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals.
| S-EPMC8479391 | biostudies-literature